Next Article in Journal
Real-World Data on the Safety and Efficacy of SBRT for Central and Ultra-Central Lung Tumors: A Retrospective Multi-Center Cohort
Previous Article in Journal
Symptom Monitoring in Ovarian Cancer Patients Treated with PARP Inhibitors: Agreement Between Physician- and Patient-Reported Toxicities Using PRO-CTCAE
Previous Article in Special Issue
Synergistic Antitumor Activity of Curcumin and the PARP1 Inhibitor PJ34 in Platinum-Sensitive and Resistant Ovarian Cancer Cells
 
 
Article

Article Versions Notes

Cancers 2026, 18(4), 651; https://doi.org/10.3390/cancers18040651
Action Date Notes Link
article html file updated 17 February 2026 10:50 CET Original file https://www.mdpi.com/2072-6694/18/4/651/html
article supplementary file uploaded. 17 February 2026 10:47 CET - https://www.mdpi.com/2072-6694/18/4/651#supplementary
article pdf uploaded. 17 February 2026 10:47 CET Version of Record https://www.mdpi.com/2072-6694/18/4/651/pdf
article xml uploaded. 17 February 2026 10:47 CET Update https://www.mdpi.com/2072-6694/18/4/651/xml
article xml file uploaded 17 February 2026 10:47 CET Original file -
Back to TopTop